No Data
No Data
Human T, Cygenia, etc.
<2160>Preparing to apply for a market classification change to the GNI Tokyo Stock Exchange Prime Market signed a business alliance (strategic partnership agreement) with Governance Partners, which handles the recruitment and management of investment funds Ortz, which handles P.A.I. (personal artificial intelligence) research and development, etc., established a joint venture with Governance Partners <3691>Digital Plus earnings forecast revised, operating profit forecast 0.25 billion yen ←△ 102 million yen <4068>Basis Downward revisions, current operating profit
Carna Biosciences: Extraordinary Report
Carna Biosciences: Confirmation
Carna Biosciences: Quarterly Report - 22nd Term 1st Quarter (2024/01/01 - 2024/03/31)
Carna Biosciences: Financial results presentation for the 1st quarter of the fiscal year ending 2024/12
Carna Biosciences: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
No Data